ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price was up 1.7% on Tuesday . The stock traded as high as $1.2590 and last traded at $1.21. Approximately 106,211 shares changed hands during trading, an increase of 423% from the average daily volume of 20,327 shares. The stock had previously closed at $1.19.
ImmunoPrecise Antibodies Stock Performance
The company has a 50-day simple moving average of $1.18 and a two-hundred day simple moving average of $1.61.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
Read More
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
